[Effect of a decarboxylase inhibitor (Ro 4-4602) and L-dopa on inhibited depressions. II. Experimental psychological studies].
作者信息
Pohlmeier H, Schön I, Matussek N
出版信息
Arzneimittelforschung. 1970 Jul;20(7):932-3.
PMID:4918920
Abstract
摘要
相似文献
1
[Effect of a decarboxylase inhibitor (Ro 4-4602) and L-dopa on inhibited depressions. II. Experimental psychological studies].[一种脱羧酶抑制剂（Ro 4-4602）和左旋多巴对抑制性抑郁的作用。II. 实验心理学研究]
Arzneimittelforschung. 1970 Jul;20(7):932-3.
2
[Effect of a decarboxylase inhibitor (Ro 4-4602) in combination with L-dopa on inhibited depressions].[一种脱羧酶抑制剂（Ro 4-4602）与左旋多巴联合使用对抑制性抑郁的作用]
Arzneimittelforschung. 1970 Jul;20(7):934-5.
3
L-dopa plus decarboxylase inhibitor in depression.
Lancet. 1970 Sep 26;2(7674):660-1. doi: 10.1016/s0140-6736(70)91425-x.
4
[2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)].左旋多巴与脱羧酶抑制剂（苄丝肼，Ro 4-4602）联合治疗帕金森病的2年经验
Wien Med Wochenschr. 1974 Jun 1;124(22):340-4.
5
[Experiences in the treatment of Parkinson's disease with a combination drug: L-dopa plus decarboxylase inhibitor (Ro 8-0576)].[联合用药（左旋多巴加脱羧酶抑制剂（Ro 8-0576））治疗帕金森病的经验]
Wien Med Wochenschr. 1973 Jun 30;123(26):433-5.
6
7
[Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor].使用左旋多巴联合脱羧酶抑制剂治疗帕金森病
Fortschr Neurol Psychiatr Grenzgeb. 1972 Oct;40(10):564-8.
8
9
[Therapy of Parkinson's syndrome with L-dopa per os combined with a decarboxylase inhibitor (Ro 46.02)].
Neurol Neurocir Psiquiatr. 1969;10(1):1-25.
Zotero 插件